Tickertape - Financial freedom begins here

Indrayani Biotech Ltd share price declined by 1.56% to Rs 10.08 after the company's net profit tumbled by 44.90% to Rs 0.54 crore, while revenue from operations eased by 0.13% to Rs 37.71 crore in Q2FY26 over Q1FY26. The market capitalization of Other Agricultural Products industry group stocks on BSE stood at Rs 56512.32 crore, gaining 6.33%. It has inched up 1.34% over last one week and gained upto 1.75% in last one month while the market capitalization of Indrayani Biotech Ltd has softened by 0.49% and 29.89% in the same period respectively. Profit before tax (PBT) of Indrayani Biotech Ltd stood at Rs 0.59 crore in Q2 FY26, expanding by 180.95% year-on-year, and tanking 153.15% quarter-on-quarter. EBITDA came in at Rs 0 crore, tumbling by 110.71% YoY and crashing by 109.02% sequentially. Total expenses posted a minor rise of 1.77% to Rs 37.33 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 32.46 crore, surging by 28.45% YoY, while employee benefits expense was at Rs 2.92 crore, plunging by 32.09% YoY. For the TTM ended FY26, revenue from operations slumped by 21.66% to Rs 130.23 crore, while net profit witnessed a sharp fall of 158.64% to Rs 6.11 crore, compared to previous TTM. EBITDA jumped by 2080% to Rs 3.13 crore, and PBT collapsed by 152.32% to Rs 5.74 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 6.74 crore in FY26, as against Rs 30.35 crore in FY25. Indrayani Biotech Ltd crashed 26.06% in last one year, underperforming the benchmark BSE Sensex which has reduced by 10.66% during the same period.

Recode Studios Limited announced the appointment of Ms. Garima Bansal as Chief Marketing Officer and Senior Management Personnel, effective October 7, 2026; Ms. Bansal holds a Bachelor’s degree in Engineering (Chemical) and has approximately one and a half years of experience in the beauty and cosmetics industry, and is the daughter of Mr. Dheeraj Bansal, Managing Director & Chairman of the Company.

Sun Pharmaceutical Industries Limited will convene a board meeting on Monday, 12 October 2026, to consider and approve the issuance of listed, rated, unsecured, redeemable non-convertible debentures (NCDs) in one or more tranches, on a private placement basis, for an aggregate amount not exceeding Rs 15,000 crore.

Alstone Textiles (India) Limited informed the BSE that compliance with Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is not applicable for the quarter and half year ended September 30, 2026, as the company has not yet initiated the issuance process for 2% Non-Convertible Preference shares approved by shareholders on September 24, 2026, amounting to Rs 5,00,00,00,000.

DJ Mediaprint & Logistics Limited informed the Bombay Stock Exchange of India Ltd and National Stock Exchange of India Ltd that it has received a certificate from Purva Sharegistry (India) Private Limited, the company's Registrar and Share Transfer Agent, for the period July 1, 2026, to September 30, 2026, confirming the dematerialization of securities in accordance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Abans Financial Services Limited announced it has entered into a Share Purchase Agreement with Siddhant Commercials Private Limited to acquire 20,70,926 equity shares, representing 6.01% of the paid-up equity share capital of Abans Finance Private Limited, a subsidiary of the company. The acquisition, at a price of Rs 111 per share, will increase Abans Financial Services Limited’s stake in Abans Finance Private Limited to 99.98% from its previous holding of 93.97%.

Hy-Tech Engineers Limited announced that it has incorporated a wholly owned subsidiary, HY-TECH ENGINEERS Inc, in the State of Delaware, United States, receiving certification of incorporation on October 7, 2026. The subsidiary, which operates in the hydraulic fittings industry, was formed with a share capital of $300,000 subscribed by Hy-Tech Engineers Limited in cash, resulting in 100% ownership.

Sera Investments & Finance India Limited informed the BSE Limited that it is enclosing a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half-year ended September 30, 2026, received from Purva Sharegistry (India) Private Limited, its Registrar and Share Transfer Agent.

Adani Ports and Special Economic Zone Limited submitted a certificate to the BSE Limited and National Stock Exchange of India Limited, received from MUFG Intime India Private Limited, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.

Jubilant Pharmova Limited will hold a board meeting on Monday, October 12, 2026, to consider and approve raising funds through the issuance of Non-Convertible Debentures (NCDs) and/or other securities, and to seek shareholder approval as required.